Ist quercetagetin in der Schwangerschaft sicher?
No EU cosmetic regulatory restriction or ban (Annex II/III) or harmonised CLP (ECHA Annex VI) classification was found for quercetagetin (CAS 90-18-6), and a search of available safety-assessment repositories (CIR/SCCS) returned no specific cosmetic safety opinion for this exact substance. PubChem lists the compound (CID 5281680) but there are no clear animal developmental/reproductive toxicity studies for topical exposure to quercetagetin in the peer‑reviewed literature—therefore default hazard (h=0), mechanism (m=0) and exposure (e=0) scores apply for pregnancy. (See PubChem entry and EU cosmetics/COSING and ECHA pages showing no specific restrictions or harmonised classification.)
Related ingredients
Frequently asked questions
- Ist quercetagetin in der Schwangerschaft sicher?
- No EU cosmetic regulatory restriction or ban (Annex II/III) or harmonised CLP (ECHA Annex VI) classification was found for quercetagetin (CAS 90-18-6), and a search of available safety-assessment repositories (CIR/SCCS) returned no specific cosmetic safety opinion for this exact substance. PubChem lists the compound (CID 5281680) but there are no clear animal developmental/reproductive toxicity studies for topical exposure to quercetagetin in the peer‑reviewed literature—therefore default hazard (h=0), mechanism (m=0) and exposure (e=0) scores apply for pregnancy. (See PubChem entry and EU cosmetics/COSING and ECHA pages showing no specific restrictions or harmonised classification.)
- Ist quercetagetin während des Stillens sicher?
- No data specific to lactation or transfer into breast milk for quercetagetin was identified in regulatory or peer‑reviewed sources; no harmonised CLP or EU cosmetic restriction applies. In the absence of substance‑specific reproductive/lactation data, and given the lack of evidence of systemic reproductive hazard for this specific flavonoid, default scores are used (h=0, m=0, e=0).
- Ist quercetagetin sicher für Babyhaut?
- No baby/infant (0–3 yr) topical safety data were identified for quercetagetin and no regulatory infant-specific restriction exists. Per the scoring rules, because there is measurable/possible dermal absorption for many small polyphenolic flavonoids (and no specific evidence showing zero absorption), exposure for baby skin is increased by +1 versus adult (adult e=0 → baby e=1) while hazard and mechanism remain default (h=0, m=0) absent infant-specific adverse data or harmonised classification.
- Wie bewertet VeriMom quercetagetin?
- VeriMom bewertet quercetagetin mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu quercetagetin?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu quercetagetin basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.